Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-02-04

Clinical Trial Update: Self-injection of Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

Phase 3 trial results evaluate self-injection of adalimumab in adult Japanese patients with rheumatoid arthritis; the study has completed and results were poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: Abbott | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2010-02-04